Current status:
Cancelled Post Market
Current status date:
2016-10-26
DIN:
02236956
Electronic product monograph is not available
Company:
PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada
H4P 2T4
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
G04BD02 FLAVOXATE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
FLAVOXATE HYDROCHLORIDE
|
200 MG
|